Harvard Catalyst Profiles

Contact, publication, and social network information about Harvard faculty and fellows.

Search Result Details

This page shows the details of why an item matched the keywords from your search.
One or more keywords matched the following items that are connected to Meyerhardt, Jeffrey
Item TypeName
Academic Article Impact of body mass index on outcomes and treatment-related toxicity in patients with stage II and III rectal cancer: findings from Intergroup Trial 0114.
Academic Article Chemotherapy options for gastric cancer.
Academic Article Adjuvant and neoadjuvant approaches in gastric cancer.
Academic Article Association of dietary patterns with cancer recurrence and survival in patients with stage III colon cancer.
Academic Article Impact of physical activity on cancer recurrence and survival in patients with stage III colon cancer: findings from CALGB 89803.
Academic Article Systemic therapy for colorectal cancer.
Academic Article Influence of body mass index on outcomes and treatment-related toxicity in patients with colon carcinoma.
Academic Article Adjuvant treatment of colorectal cancer.
Academic Article Adjuvant therapy for stage II and III colon cancer.
Academic Article Relationship between statin use and colon cancer recurrence and survival: results from CALGB 89803.
Academic Article Impact of diabetes mellitus on outcomes in patients with colon cancer.
Academic Article Patterns of adjuvant chemotherapy use in a population-based cohort of patients with resected stage II or III colon cancer.
Academic Article Multivitamin use is not associated with cancer recurrence or survival in patients with stage III colon cancer: findings from CALGB 89803.
Academic Article Adjuvant therapy in gastric cancer: can we prevent recurrences?
Academic Article New developments in the adjuvant therapy of stage II colon cancer. Risk assessments in the older patient.
Academic Article Impact of body mass index and weight change after treatment on cancer recurrence and survival in patients with stage III colon cancer: findings from Cancer and Leukemia Group B 89803.
Academic Article Impact of hospital procedure volume on surgical operation and long-term outcomes in high-risk curatively resected rectal cancer: findings from the Intergroup 0114 Study.
Academic Article Effect of adjuvant chemotherapy on survival of patients with stage III colon cancer diagnosed after age 75 years.
Academic Article Comparative effectiveness of oxaliplatin vs non-oxaliplatin-containing adjuvant chemotherapy for stage III colon cancer.
Academic Article Predictive and prognostic roles of BRAF mutation in stage III colon cancer: results from intergroup trial CALGB 89803.
Concept Chemotherapy, Adjuvant
Academic Article Impact of age on the efficacy of newer adjuvant therapies in patients with stage II/III colon cancer: findings from the ACCENT database.
Academic Article The impact of glycemic levels in patients with colon cancer.
Academic Article Patterns of physical activity participation across the cancer trajectory in colorectal cancer survivors.
Academic Article Predictive and prognostic analysis of PIK3CA mutation in stage III colon cancer intergroup trial.
Academic Article Chemotherapy usage patterns in a US-wide cohort of patients with metastatic colorectal cancer.
Academic Article Aspirin and COX-2 inhibitor use in patients with stage III colon cancer.
Academic Article Coffee Intake, Recurrence, and Mortality in Stage III Colon Cancer: Results From CALGB 89803 (Alliance).
Academic Article The IDEA (International Duration Evaluation of Adjuvant Chemotherapy) Collaboration: Prospective Combined Analysis of Phase III Trials Investigating Duration of Adjuvant Therapy with the FOLFOX (FOLFOX4 or Modified FOLFOX6) or XELOX (3 versus 6 months) Regimen for Patients with Stage III Colon Cancer: Trial Design and Current Status.
Academic Article Muscle mass at the time of diagnosis of nonmetastatic colon cancer and early discontinuation of chemotherapy, delays, and dose reductions on adjuvant FOLFOX: The C-SCANS study.
Academic Article Nut Consumption and Survival in Patients With Stage III Colon Cancer: Results From CALGB 89803 (Alliance).
Academic Article The hard road to data interpretation: 3 or 6 months of adjuvant chemotherapy for patients with stage III colon cancer?
Academic Article Duration of Adjuvant Chemotherapy for Stage III Colon Cancer.
Academic Article Association of Survival With Adherence to the American Cancer Society Nutrition and Physical Activity Guidelines for Cancer Survivors After Colon Cancer Diagnosis: The CALGB 89803/Alliance Trial.
Academic Article Duration of Oxaliplatin-Containing Adjuvant Therapy for Stage III Colon Cancer: ASCO Clinical Practice Guideline.
Academic Article Translating IDEA to Practice and Beyond: Managing Stage II and III Colon Cancer.
Academic Article Effect of duration of adjuvant chemotherapy for patients with stage III colon cancer (IDEA collaboration): final results from a prospective, pooled analysis of six randomised, phase 3 trials.
Academic Article Recruitment strategies and design considerations in a trial of resistance training to prevent dose-limiting toxicities in colon cancer patients undergoing chemotherapy.
Academic Article Effect of Celecoxib vs Placebo Added to Standard Adjuvant Therapy on Disease-Free Survival Among Patients With Stage III Colon Cancer: The CALGB/SWOG 80702 (Alliance) Randomized Clinical Trial.
Academic Article Determining the optimal duration of adjuvant therapy in colon cancer.
Search Criteria
  • Chemotherapy Adjuvant
Funded by the NIH National Center for Advancing Translational Sciences through its Clinical and Translational Science Awards Program, grant number UL1TR002541.